The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor genomic analysis for biomarker identification in a phase I trial of the Wee 1 inhibitor adavosertib (AZD1775).
 
Abdul Rafeh Naqash
No Relationships to Disclose
 
Arjun Mittra
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Li Chen
No Relationships to Disclose
 
Biswajit Das
Research Funding - Illumina (Inst)
 
Shivaani Kummar
Stock and Other Ownership Interests - Drishti
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Corvus Pharmaceuticals; Genentech; Harbour BioMed; MedTree (I); Mundipharma; Nodus Therapeutics; Seagen; ShangPharma Innovation
Research Funding - ADC Therapeutics (Inst); Advenchen Laboratories (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Dynavax Technologies (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Pfizer (Inst); Plexxikon (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bayer
 
Khanh T Do
No Relationships to Disclose
 
Ting-Chia Chang
No Relationships to Disclose
 
Ashley Bruns
No Relationships to Disclose
 
Lamin Juwara
No Relationships to Disclose
 
Brandon Miller
No Relationships to Disclose
 
Robert J. Kinders
No Relationships to Disclose
 
Ralph E. Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - SciTech Development LLC
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; Named Inventor on US Patent 9,644,037; Named inventor on US Patent US8709379 B2
Travel, Accommodations, Expenses - Sanofi/Aventis
 
Larry V Rubinstein
No Relationships to Disclose
 
Jiuping Jay Ji
No Relationships to Disclose
 
Deborah Wilsker
No Relationships to Disclose
 
Angie B Dull
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Alice P. Chen
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose